Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ceconomy AG meldet starkes Umsatz- und EBIT-Wachstum für Q4 2025 (Investing.com DE) +++ CECONOMY Aktie -3,30%

ACCURAY Aktie

 >ACCURAY Aktienkurs 
0.895 EUR    +3.5%    (Tradegate)
Ask: 0.895 EUR / 4458 Stück
Bid: 0.85 EUR / 4719 Stück
Tagesumsatz: 350 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ACCURAY Aktie über LYNX handeln
>ACCURAY Performance
1 Woche: +6,0%
1 Monat: -6,9%
3 Monate: -35,8%
6 Monate: -16,2%
1 Jahr: -52,4%
laufendes Jahr: -52,2%
>ACCURAY Aktie
Name:  ACCURAY INC. DL -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0043971052 / A0MKWM
Symbol/ Ticker:  XEJ (Frankfurt) / ARAY (NASDAQ)
Kürzel:  FRA:XEJ, ETR:XEJ, XEJ:GR, NASDAQ:ARAY
Index:  -
Webseite:  http://www.accuray.com
Profil:  Accuray Incorporated is a medical device company s..
>Volltext..
Marktkapitalisierung:  106.2 Mio. EUR
Unternehmenswert:  204.33 Mio. EUR
Umsatz:  384.07 Mio. EUR
EBITDA:  6.59 Mio. EUR
Nettogewinn:  -16.45 Mio. EUR
Gewinn je Aktie:  -0.14 EUR
Schulden:  152.56 Mio. EUR
Liquide Mittel:  54.44 Mio. EUR
Operativer Cashflow:  19.02 Mio. EUR
Bargeldquote:  0.33
Umsatzwachstum:  -3.69%
Gewinnwachstum:  -10.87%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 19.410 USD.
Suchwörter:  ACCURAY
Letzte Datenerhebung:  17.12.25
>ACCURAY Kennzahlen
Aktien/ Unternehmen:
Aktien: 113.34 Mio. St.
Frei handelbar: 95.24%
Rückkaufquote: -1.3%
Mitarbeiter: 990
Umsatz/Mitarb.: 0.39 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 269.71%
Bewertung:
KGV: -
KGV lG: -
KUV: 0.3
KBV: 1.94
PEG-Ratio: -
EV/EBITDA: 30.99
Rentabilität:
Bruttomarge: 30.93%
Gewinnmarge: -4.28%
Operative Marge: 0.04%
Managementeffizenz:
Gesamtkaprendite: -4.15%
Eigenkaprendite: -36.07%
>ACCURAY Peer Group

Es sind 599 Aktien bekannt.
 
16.12.25 - 19:21
Radiation Therapy-Focused Accuray Details Workforce Reduction, Outsourcing In Major Transformation Push (Benzinga)
 
Accuray outlines a restructuring plan aimed at $25 million in annual profit gains through cost cuts, workforce reduction and operational realignment. read more...
15.12.25 - 23:18
Accuray-Aktie legt nach Ankündigung eines 25-Millionen-Dollar-Sparprogramms zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
15.12.25 - 23:03
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth (PR Newswire)
 
Plan includes organizational realignment, rightsizing of cost structure, outsourcing, and sales enablement in order to enhance competitiveness and support long-term strategy. Workforce optimization actions will affect approximately 15% of the company's employees. Of the expected $25......
20.11.25 - 02:02
Insiderhandel: CEO kauft Aktien von Accuray im Wert von 19410 USD (Insiderkauf)
 
La, Neve Stephen R. - Vorstand - Tag der Transaktion: 2025-11-19...
06.11.25 - 00:45
Accuray outlines transformation plan with adjusted EBITDA margin targets amid margin pressures and service revenue growth (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 23:42
Earnings Call: Accuray verfehlt Gewinnprognose deutlich, Aktie legt dennoch zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 22:27
Accuray GAAP EPS of -$0.18 misses by $0.12, revenue of $93.9M beats by $2.55M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 22:06
Accuray Reports Fiscal 2026 First Quarter Financial Results (PR Newswire)
 
MADISON, Wis., Nov. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025. Key Highlights On October 20, 2025, the Company announced accelerated transformation efforts, including: Appointed Steve La Neve......
31.10.25 - 21:06
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules (PR Newswire)
 
MADISON, Wis., Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new Chief Executive Officer. As a material inducement to Mr. La Neve joining the company, and in......
28.10.25 - 12:39
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025 (PR Newswire)
 
MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025. The......
20.10.25 - 15:26
Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth (PR Newswire)
 
Industry Veteran Steve La Neve Named Chief Executive Officer Suzanne Winter to Retire as President and CEO Company Appoints Steven F. Mayer as Transformation Board Sponsor Chan W. Galbato Nominated to Board of Directors MADISON, Wis., Oct. 20, 2025 /PRNewswire/ -- Accuray Incorporated......
08.10.25 - 13:36
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System (PR Newswire)
 
5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia. MADISON, Wis., Oct. 8, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that 5D......
30.09.25 - 13:39
Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care (PR Newswire)
 
MADISON, Wis., Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray......
26.09.25 - 13:36
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care (PR Newswire)
 
New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy to Each Patient's Unique Needs MADISON, Wis., Sept. 26, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that......
18.09.25 - 17:30
Here′s Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
 
ARAY sees strong order momentum, APAC growth and CyberKnife demand, but soft product sales and regional headwinds cloud near-term gains....
11.09.25 - 22:12
Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025 (PR Newswire)
 
Event Will Feature Global KOLs Sharing Their Perspectives on the Role of Adaptive Radiotherapy in Radiation Medicine MADISON, Wis., Sept. 11, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on......
14.08.25 - 19:00
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
 
ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness....
14.08.25 - 14:00
Accuray Q4 Revenue Hits $128 Million (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
14.08.25 - 01:18
Accuray targets $471M–$485M revenue in fiscal 2026 as service business growth offsets geopolitical headwinds (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.08.25 - 01:00
Accuray (ARAY) Reports Break-Even Earnings for Q4 (Zacks)
 
Accuray (ARAY) delivered earnings and revenue surprises of -100.00% and +2.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!